Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 4 (2007), Issue 12 (December)

1. Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
   Am J Physiol Heart Circ Physiol, 293(6): H3602-7. [Abstract] [Full-text]
2. Patients with schizophrenia and their finances: how they spend their money.
   Soc Psychiatry Psychiatr Epidemiol, 42(12): 977-83. [Abstract] [Full-text]
3. Affect processing and positive syndrome schizotypy in cannabis users.
   Psychiatry Res, 157(1): 279-82. [Abstract] [Full-text]
4. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.
   Brain, 130: 3091-101. [Abstract] [Full-text]
5. The Efficacy of a Multicultural Prevention Intervention among Urban American Indian Youth in the Southwest U.S.
   J Prim Prev. [Abstract] [Full-text]
6. What's being used to spike your drink? Alleged spiked drink cases in inner city London.
   Postgrad Med J, 83(986): 754-8. [Abstract] [Full-text]
7. Cannabis use and self-reported collisions in a representative sample of adult drivers.
   J Safety Res, 38(6): 669-74. [Abstract] [Full-text]
8. Associations Between Substance Use, Erectile Dysfunction Medication and Recent HIV Infection Among Men Who have Sex with Men.
   AIDS Behav. [Abstract] [Full-text]
9. Safer choices 2: Rationale, design issues, and baseline results in evaluating school-based health promotion for alternative school students.
   Contemp Clin Trials, 29(1): 70-82. [Abstract] [Full-text]
10. A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances.
    Drug Alcohol Depend, 92(1): 48-54. [Abstract] [Full-text]
11. Are diagnostic orphans at risk of developing cannabis abuse or dependence? Four-year follow-up of young adult cannabis users not meeting diagnostic criteria.
    Drug Alcohol Depend, 92(1): 86-90. [Abstract] [Full-text]
12. Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age.
    Drug Alcohol Depend, 92(1): 239-47. [Abstract] [Full-text]
13. Characteristics of drug-related hospital separations in Australia.
    Drug Alcohol Depend, 92(1): 149-55. [Abstract] [Full-text]
14. An analysis of racial and sex differences for smoking among adolescents in a juvenile correctional center.
    Drug Alcohol Depend, 92(1): 156-63. [Abstract] [Full-text]
15. The incremental inpatient costs associated with marijuana comorbidity.
    Drug Alcohol Depend, 92(1): 248-57. [Abstract] [Full-text]
16. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study.
    Neuropsychopharmacology, 33(2): 247-58. [Abstract] [Full-text]
17. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder.
    Psychol Med. [Abstract] [Full-text]
18. Using correlational evidence to select youth for prevention programming.
    J Prim Prev, 28(5): 421-47. [Abstract] [Full-text]
19. Endocannabinoids in TNF-alpha and Ethanol Actions.
    Neuroimmunomodulation, 14(3): 188-92. [Abstract] [Full-text]
20. Pilot test of Project CHOICE: a voluntary afterschool intervention for middle school youth.
    Psychol Addict Behav, 21(4): 592-8. [Abstract] [Full-text]
21. Evaluations and expectancies of alcohol and marijuana problems among college students.
    Psychol Addict Behav, 21(4): 545-54. [Abstract] [Full-text]
22. Spatial working memory performance and fMRI activation interaction in abstinent adolescent marijuana users.
    Psychol Addict Behav, 21(4): 478-87. [Abstract] [Full-text]
23. Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder.
    J Psychiatr Res. [Abstract] [Full-text]
24. Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H(2)O(2), and K(ATP) channels.
    Neurochem Int, 52(1): 80-8. [Abstract] [Full-text]
25. Behavioral economic analysis of drug preference using multiple choice procedure data.
    Drug Alcohol Depend, 93(1): 103-10. [Abstract] [Full-text]
26. Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample.
    Drug Alcohol Depend, 93(1): 12-20. [Abstract] [Full-text]
27. Alcohol, drugs, and condom use among drug offenders: an event-based analysis.
    Drug Alcohol Depend, 93(1): 38-42. [Abstract] [Full-text]
28. Investigating the long-term influence of adolescent delinquency on drug use initiation.
    Drug Alcohol Depend, 93(1): 72-84. [Abstract] [Full-text]
29. Smoking, alcohol and drug use among vocational dental practitioners in 2000 and 2005.
    Br Dent J, 203(12): 701-5. [Abstract] [Full-text]
30. Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.
    Psychol Med, 38(1): 79-88. [Abstract] [Full-text]
31. Perceived parenting styles and tobacco, alcohol and cannabis use among French adolescents: gender and family structure differentials.
    Alcohol Alcohol, 43(1): 73-80. [Abstract] [Full-text]
32. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: A descriptive epidemiologic study.
    Head Neck, 30(1): 75-84. [Abstract] [Full-text]
33. School-based programmes to prevent alcohol, tobacco and other drug use.
    Int Rev Psychiatry, 19(6): 607-615. [Abstract] [Full-text]
34. Membranous glomerulonephritis may be associated with heavy marijuana abuse.
    Transplant Proc, 39(10): 3054-6. [Abstract] [Full-text]
35. Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids.
    Neuron, 56(6): 1034-47. [Abstract] [Full-text]
36. "Recreational" drug abuse associated with failure to mount a proper antibody response after a generalised orthopoxvirus infection.
    Infection, 35(6): 469-73. [Abstract] [Full-text]
37. Psychiatric and familial predictors of transition times between smoking stages: results from an offspring-of-twins study.
    Addict Behav, 33(2): 235-51. [Abstract] [Full-text]
38. Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity.
    J Med Chem, 50(26): 6493-500. [Abstract] [Full-text]
39. Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence.
    J Psychiatr Res, 42(3): 230-9. [Abstract] [Full-text]
40. EEG of chronic marijuana users during abstinence: relationship to years of marijuana use, cerebral blood flow and thyroid function.
    Clin Neurophysiol, 119(2): 321-31. [Abstract] [Full-text]
41. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Brain Res, 1188: 157-64. [Abstract] [Full-text]
42. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study.
    Am J Med Genet B Neuropsychiatr Genet, 147(1): 10-7. [Abstract] [Full-text]
43. Use of a population-based survey to describe the health of Boston public housing residents.
    Am J Public Health, 98(1): 85-91. [Abstract] [Full-text]
44. The consumption of khat and other drugs in somali combatants: a cross-sectional study.
    PLoS Med, 4(12): e341. [Abstract] [Full-text]
45. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Am J Drug Alcohol Abuse, 34(1): 75-82. [Abstract] [Full-text]
46. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.
    Neuropharmacology, 54(1): 95-107. [Abstract] [Full-text]
47. Cocaine treatment admissions at three sentinel sites in South Africa (1997-2006): findings and implications for policy, practice and research.
    Subst Abuse Treat Prev Policy, 2(1): 37. [Abstract] [Full-text]
48. Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia.
    Neuropharmacology, 54(1): 161-71. [Abstract] [Full-text]
49. Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
    Neuropharmacology, 54(1): 181-8. [Abstract] [Full-text]
50. Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
    Neuropharmacology, 54(1): 235-43. [Abstract] [Full-text]

© 2004-2008 Marijuana Research Today. All Rights Reserved.